Immunomedics Inc

300 American Road
Morris Plains NJ 07950
United States

  • With Kompass :
  • Global presence in more than 60 countries
  • Detailed and up to date company information
  • Comprehensive and filtered company directory

Company Summary

Immunomedics, Inc. (Immunomedics) is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The Company has developed a advanced technologies that allow to create humanized antibodies that can be used either alone in unlabeled, or naked form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, the Company has built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. It has licensed the lead product candidate, epratuzumab, to Ucb, S.A. (Ucb) for the treatment of all autoimmune disease indications. The Company has retained the rights for epratuzumab in oncology indications for which Ucb has been granted a buy-in option.

General Information

Key figures

Employees

  • Company

    100-249 Employees

Turnover

  • 2009

    25 to 50 million USD

Executives

Executive information

  • Cynthia Sullivan

    President, CEO, Director; President, CEO, and Director

  • D. G.

    Chairman of the Board, Chief Strategic Officer; Chairman of the Board, Chief Scientific Officer, Chief Medical Officer

  • D. S.

    CEO

  • E. W.

    consultant

  • G. G.

    CFO, VP - Finance

  • I. H.

    Executive VP for Research and Development

  • J. M.

    VP, General Counsel

  • M. P.

    VP,CFO

  • G. G.

    Chief Financial Officer, Senior Vice President - Finance and Business Developmen

  • M. P.

    Executive Director

  • K. C.

    Executive Director / Quality

  • I. W.

    Vice President

  • D. P.

    Vice President

  • O. M.

    Vice President

  • D. S.

    Vice President

  • J. P.

    Vice President

  • A. P.

    Chief Marketing Officer

  • D. G.

    Chairman, Chief Scientific Officer, and Chief Medical Officer

  • C. C.

    Business Development

  • P. P.

    VP Finance and CFO

  • C. S.

    President & Chief Executive Officer

  • T. C.

    Scientist Preclinical Development

  • J. A.

    Management Information Systems / Information Systems / Information Technology Manager

  • C. S.

    Operations Executive

  • D. O.

    Board Member

  • J. S.

    Director, QA and Compliance

  • K. Z.

    Independent Director

  • R. M.

    Director. Manufacturing

  • E. R.

    Director of Call Center

Activities

Activities

  • Producer
  • Distributor
  • Service provider

Other classifications (for some countries)

SIC (US 1987) :
Diagnostic substances (2835)
NAICS (US 2012) :
In-Vitro Diagnostic Substance Manufacturing (325413)

You might also like

You might also like:

Our business solutions